EW Edwards Lifesciences Corp

Price (delayed)

$92.17

Market cap

$57.3B

P/E Ratio

68.27

Dividend/share

N/A

EPS

$1.35

Enterprise value

$56.81B

Sector: Healthcare
Industry: Medical Devices

Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of ...

Highlights

The equity has grown by 19% year-on-year
EW's quick ratio is up by 16% year-on-year and by 12% since the previous quarter
The company's EPS fell by 24% YoY but it rose by 2.3% QoQ
The net income has contracted by 23% YoY but it has grown by 3.4% from the previous quarter
The price to earnings (P/E) is 43% higher than the 5-year quarterly average of 47.6 and 8% higher than the last 4 quarters average of 63.0
The debt has grown by 2% YoY

Key stats

What are the main financial stats of EW
Market
Shares outstanding
621.64M
Market cap
$57.3B
Enterprise value
$56.81B
Valuations
Price to earnings (P/E)
68.27
Price to book (P/B)
12.36
Price to sales (P/S)
12.84
EV/EBIT
59.34
EV/EBITDA
51.59
EV/Sales
12.7
Earnings
Revenue
$4.47B
EBIT
$957.3M
EBITDA
$1.1B
Free cash flow
$717M
Per share
EPS
$1.35
Free cash flow per share
$1.15
Book value per share
$7.46
Revenue per share
$7.18
TBVPS
$9.17
Balance sheet
Total assets
$7.21B
Total liabilities
$2.56B
Debt
$688.8M
Equity
$4.66B
Working capital
$2.27B
Liquidity
Debt to equity
0.15
Current ratio
3.84
Quick ratio
2.5
Net debt/EBITDA
-0.44
Margins
EBITDA margin
24.6%
Gross margin
75.2%
Net margin
19%
Operating margin
20.9%
Efficiency
Return on assets
12.3%
Return on equity
19.7%
Return on invested capital
22.9%
Return on capital employed
14.9%
Return on sales
21.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

EW stock price

How has the Edwards Lifesciences stock price performed over time
Intraday
0.46%
1 week
-3.51%
1 month
9.57%
1 year
26.82%
YTD
1.03%
QTD
10.2%

Financial performance

How have Edwards Lifesciences's revenue and profit performed over time
Revenue
$4.47B
Gross profit
$3.37B
Operating income
$934.3M
Net income
$851M
Gross margin
75.2%
Net margin
19%
The operating income has contracted by 23% YoY but it has grown by 2.5% from the previous quarter
The net income has contracted by 23% YoY but it has grown by 3.4% from the previous quarter
The net margin has contracted by 23% YoY
The company's operating margin fell by 23% YoY

Growth

What is Edwards Lifesciences's growth rate over time

Valuation

What is Edwards Lifesciences stock price valuation
P/E
68.27
P/B
12.36
P/S
12.84
EV/EBIT
59.34
EV/EBITDA
51.59
EV/Sales
12.7
The price to earnings (P/E) is 43% higher than the 5-year quarterly average of 47.6 and 8% higher than the last 4 quarters average of 63.0
The company's EPS fell by 24% YoY but it rose by 2.3% QoQ
The stock's price to book (P/B) is 24% more than its 5-year quarterly average of 10.0 and 7% more than its last 4 quarters average of 11.6
The equity has grown by 19% year-on-year
The P/S is 40% above the 5-year quarterly average of 9.2 and 12% above the last 4 quarters average of 11.5
EW's revenue is up by 2% since the previous quarter

Efficiency

How efficient is Edwards Lifesciences business performance
The company's return on invested capital fell by 38% YoY
EW's return on assets is down by 33% year-on-year
Edwards Lifesciences's return on equity has decreased by 32% YoY
The company's return on sales fell by 25% YoY

Dividends

What is EW's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EW.

Financial health

How did Edwards Lifesciences financials performed over time
The total assets is 182% greater than the total liabilities
The total assets is up by 19% year-on-year
The company's total liabilities rose by 17% YoY but it fell by 4% QoQ
The debt is 85% less than the equity
The equity has grown by 19% year-on-year
The company's debt to equity fell by 12% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.